XML 31 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Total revenues $ 277,246 $ 232,284 $ 722,683
Operating expenses:      
Cost of sales - product 49,445 50,167 262,153
Research and development 61,550 54,886 46,600
Selling, general and administrative 170,373 152,946 131,408
Gain on sale of assets (Note 8) 0 (1,000) (1,000)
Bad debt expense (Note 9) 0 12,313 0
Total operating expenses 281,368 269,312 439,161
(Loss) income from operations (4,122) (37,028) 283,522
Other (expense) income:      
Interest income 36,464 31,993 7,912
Interest expense (6,794) (6,757) (6,732)
Sublease income 5,014 7,577 7,685
Change in fair value of warrant liability (Note 14) 0 0 1,801
Other 293 (152) 111
Net income (loss) before income taxes 30,855 (4,367) 294,299
Provision for income taxes (3,546) (2,022) (1,143)
Net income (loss) 27,309 (6,389) 293,156
Undistributed earnings allocated to participating securities 0 0 (283)
Net (loss) income allocable to common stockholders, basic (in USD per share) $ 27,309 $ (6,389) $ 292,873
Net income (loss) per share allocable to common stockholders      
Basic (in USD per share) $ 0.21 $ (0.05) $ 2.32
Diluted (in USD per share) $ 0.20 $ (0.05) $ 1.97
Weighted-average shares used in computing net income (loss) per share allocable to common stockholders:      
Basic (in shares) 130,047 128,733 126,398
Diluted (in shares) 133,344 128,733 150,797
Product revenue      
Revenues:      
Total revenues $ 268,430 $ 213,295 $ 713,645
Other revenue      
Revenues:      
Total revenues $ 8,816 $ 18,989 $ 9,038